Follow the HLB테라퓨틱스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HLB테라퓨틱스 has recorded 59 insider filings. Market capitalisation: €153.4bn. The latest transaction was reported on 10 June 2026 (Purchase). Among the most active insiders: HLB. Every trade is free.
57
Insider Decl.
n/a
Thresholds
€49,275
43 ops.
Buy Volume
n/a
1 ops.
Sell Volume
17Σ signal
Buys €49,275n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,209 of 28,932 companies
17.1
score / 100
Value
19
Quality
15
FCF yld-9.7%
Earn yld-4.9%
EV/EBITDA·
ROE-11%
Gross mgn15%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
HLB테라퓨틱스 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.